Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6186 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Centre to address global epilepsy challenges launched at Oxford’s Wolfson College

The University of Oxford is launching The Centre for Global Epilepsy to address the global burden of epilepsy, particularly in lower-income countries.

Oxford success in the 2024 Lasker Essay Contest

Subashan Vadibeler, a recent Oxford Rhodes scholar and Department of Oncology student, is one of five co-winners of the international 2024 Lasker Essay Contest, sponsored by the Lasker Foundation.

Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies

Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on ground-breaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.

Côte d’Ivoire makes history as first nation to deploy R21/Matrix-M™ Malaria Vaccine

Today marks the official rollout of the new R21/Matrix-M™ malaria vaccine - co-developed by the University of Oxford and Serum Institute of India, leveraging Novavax’s Matrix-M™ adjuvant technology. In a historic step in the battle to beat malaria, the first official vaccination is due to take place in Abidjan, Côte d’Ivoire, this morning and will be subsequently rolled-out in 38 districts across the country.

COVID-19 phone apps shown to provide real-time information on the spread of infectious diseases

Researchers analysing data from mobile phone apps used during the COVID-19 pandemic found that digital contact tracing provides rich insights into epidemic dynamics with unprecedented resolution and speed, revealing how transmission varied by day of the week, gatherings during the 2021 Christmas period, and the UEFA Euro football tournament in July 2021

Open Access Updates

Oxford University research showcased at the 2024 Royal Society Summer Science Exhibition

University of Oxford research will be on display at the Royal Society’s flagship public engagement event, the Summer Science Exhibition, which launches this year on Tuesday 2 July in central London. This historic annual event, which has been running for more than 200 years, expects to attract more than 10,000 visitors seeking the latest cutting-edge science.

Science Together celebrates a third year of community-led research collaborations

Science Together hosts a Summer Celebration to recognise the seven community-led research collaborations formed over the last ten months through the Science Together engagement with research programme.

Major UK study reveals shifting trends and persistent challenges in heart disease over the last 20 years

A groundbreaking new study has shed light on how the landscape of heart disease has evolved in the UK over the past two decades. Researchers analyzed electronic health records from the Clinical Practice Research Datalink (CPRD GOLD and Aurum), encompassing a representative cohort of 22 million individuals. This included 1,650,052 people newly diagnosed with at least one cardiovascular disease (CVD) between 2000 and 2019, with an average age of 70.5 years, of whom 48% were women.

The Centre for Research Equity launches historic partnership to advance health equity in Northern Ireland

The Centre for Research Equity partners with Northern Ireland to advance health equity. This groundbreaking collaboration aims to improve health outcomes, reduce disparities, and ensure research benefits all communities through inclusive, community-driven approaches.

First UK trial of Deep Brain Stimulation for children with epilepsy begins

A teenager who is the first patient to take part in a UK clinical trial to use deep brain stimulation to treat epilepsy has seen his daytime seizures reduce by 80%.

Cholesterol-lowering drug slows progression of eye disease in people with diabetes

The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression of diabetic retinopathy by 27%. The results were announced today at the American Diabetes Association Scientific Sessions and published in NEJM Evidence.

Poor metabolic health linked to worse brain health

People with poor metabolic health are more likely to have memory and thinking problems and worse brain health, according to a new study by researchers at Nuffield Department of Population Health. The study is published in Diabetes Care, and is the largest study into metabolic and brain health to date

Members of the Medical Sciences Division recognised in the King’s Birthday Honours 2024

Professor Freddie Hamdy, Prof Rajesh Vasantlal Thakker, Prof Claudia Turner, Prof Paul Turner and Prof Rachel Upthegrove have been recognised and celebrated in the 2024 King's Birthday Honours list.

June 2024 - Volunteer Opportunities

Study demonstrates how AI can develop more personalised cancer treatment strategies

University of Oxford researchers have leveraged the power of artificial intelligence (AI) to develop personalised cancer treatments which could be more effective at preventing patient relapse.

New MSD Safety Resource Hub

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

Sildenafil (‘Viagra’) improves brain blood flow and could help to prevent dementia

A new trial conducted by the University of Oxford reveals that sildenafil, commonly known as Viagra, enhances blood flow to the brain and improves the function of brain blood vessels in patients at a heightened risk of vascular dementia.

PRINCIPLE and PANORAMIC teams honoured with prestigious Prix Galien Award

The teams behind the PRINCIPLE and PANORAMIC clinical trials, run in the Clinical Trials Unit at the Nuffield Department of Primary Care Health Sciences, have been awarded the prestigious Prix Galien Best Public Sector Innovation Award 2024 for their work in conducting innovative, large-scale clinical trials during the COVID-19 pandemic.

Load More